Literature DB >> 22591112

Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models.

Kristian Bolin1.   

Abstract

BACKGROUND: Smoking is probably the most important among preventable health risks. Health economic evaluation of smoking-cessation interventions, applying a lifetime perspective, is made possible by available epidemiological knowledge. The well established method of performing cost-effectiveness analyses of smoking-cessation interventions involves mathematical modelling (both deterministic and stochastic) of future events important for cost effectiveness.
OBJECTIVES: This study surveys cost-effectiveness analyses of smoking cessation, with a particular focus on the mathematical modelling and simulation analyses performed. DATA SOURCES: A systematic literature search was performed using the databases MEDLINE, Econlit and Academic Search Complete. STUDY SELECTION: Health economic evaluations, published as full-length journal articles, were searched for.
RESULTS: 423 studies were identified and 78 were finally included, of which 30 were assessed as being highly relevant, based on the application of simulation modelling.
CONCLUSIONS: In general, studies are well performed as regards modelling. Common weaknesses include reporting of modelling details; validation of used simulation models; and the handling of structural uncertainty and different types of heterogeneity.

Mesh:

Year:  2012        PMID: 22591112     DOI: 10.2165/11590120-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  59 in total

1.  How good is the Prevent model for estimating the health benefits of prevention?

Authors:  H Brønnum-Hansen
Journal:  J Epidemiol Community Health       Date:  1999-05       Impact factor: 3.710

Review 2.  Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.

Authors:  Fujian Song; James Raftery; Paul Aveyard; Chris Hyde; Pelham Barton; Nerys Woolacott
Journal:  Med Decis Making       Date:  2002 Sep-Oct       Impact factor: 2.583

Review 3.  The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.

Authors:  N F Woolacott; L Jones; C A Forbes; L C Mather; A J Sowden; F J Song; J P Raftery; P N Aveyard; C J Hyde; P M Barton
Journal:  Health Technol Assess       Date:  2002       Impact factor: 4.014

4.  Accounting for future costs in medical cost-effectiveness analysis.

Authors:  D Meltzer
Journal:  J Health Econ       Date:  1997-02       Impact factor: 3.883

5.  Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea.

Authors:  Jung Youn Bae; Cheol Hwan Kim; Eui Kyung Lee
Journal:  Value Health       Date:  2009 Nov-Dec       Impact factor: 5.725

6.  Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.

Authors:  Kristian Bolin; Koo Wilson; Hicham Benhaddi; Enrico de Nigris; Sophie Marbaix; Ann-Christin Mork; Henri-Jean Aubin
Journal:  Eur J Public Health       Date:  2009-06-02       Impact factor: 3.367

7.  The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.

Authors:  Chris Knight; Paul Howard; Christine L Baker; Jeno P Marton
Journal:  Value Health       Date:  2009-11-13       Impact factor: 5.725

8.  Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom.

Authors:  M J Thun; L F Apicella; S J Henley
Journal:  JAMA       Date:  2000-08-09       Impact factor: 56.272

9.  The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts.

Authors:  Tammy O Tengs; Sajjad Ahmad; Jennifer M Savage; Rebecca Moore; Eric Gage
Journal:  Prev Med       Date:  2005-02       Impact factor: 4.018

10.  Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.

Authors:  Kristian Bolin; Ann-Christin Mörk; Stefan Willers; Björn Lindgren
Journal:  Respir Med       Date:  2008-03-04       Impact factor: 3.415

View more
  9 in total

1.  Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.

Authors:  Denis Getsios; Jenő P Marton; Nikhil Revankar; Alexandra J Ward; Richard J Willke; Dale Rublee; K Jack Ishak; James G Xenakis
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

2.  Smoking Cessation: A Comparison of Two Model Structures.

Authors:  Becky Pennington; Alex Filby; Lesley Owen; Matthew Taylor
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

3.  Gender difference and effect of pharmacotherapy: findings from a smoking cessation service.

Authors:  N J Walker; H C van Woerden; V Kiparoglou; Y Yang; H Robinson; E Croghan
Journal:  BMC Public Health       Date:  2016-10-03       Impact factor: 3.295

Review 4.  Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.

Authors:  Marrit L Berg; Kei Long Cheung; Mickaël Hiligsmann; Silvia Evers; Reina J A de Kinderen; Puttarin Kulchaitanaroaj; Subhash Pokhrel
Journal:  Addiction       Date:  2017-02-15       Impact factor: 6.526

5.  Cost-effectiveness of a high-intensity versus a low-intensity smoking cessation intervention in a dental setting: long-term follow-up.

Authors:  Inna Feldman; Asgeir Runar Helgason; Pia Johansson; Åke Tegelberg; Eva Nohlert
Journal:  BMJ Open       Date:  2019-08-15       Impact factor: 2.692

6.  Protocol for a systematic review of economic evaluations of preoperative smoking cessation interventions for preventing surgical complications.

Authors:  Nikki McCaffrey; Julie Higgins; Anita Lal
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

7.  Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model.

Authors:  Qi Wu; Simon Gilbody; Jinshuo Li; Han-I Wang; Steve Parrott
Journal:  Value Health       Date:  2021-06-03       Impact factor: 5.725

Review 8.  Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.

Authors:  Pieter T de Boer; Geert W J Frederix; Talitha L Feenstra; Pepijn Vemer
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

9.  Economic evaluation of a brief counselling for smoking cessation in dentistry: a case study comparing two health economic models.

Authors:  Suvi Erika Virtanen; Maria R Galanti; Pia M Johansson; Inna Feldman
Journal:  BMJ Open       Date:  2017-07-20       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.